This is the authors' abstract. We don't add key points for this paper.
From 1969 to 1977, 53 patients with surgical-pathologic stages II and III endometrial carcinoma were seen at the Istituto Nazionale Tumori of Milan. The treatment was individualized. The 5-year survival was 68.8% in stage II and 75.3% in stage III. The relapse-free survival was 68.9% and 69.4%, respectively. Adjuvant type of radiotherapy, degree of differentiation, depth of myometrial invasion, and especially sites of disease were the factors influencing survival.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Palo et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: